Luxury as a way of life! At every touchpoint, Bharat is about evolution through inclusivity: Haresh Mirpuri, Aranyani

Luxury as a way of life! At every touchpoint, Bharat is about evolution through inclusivity: Haresh Mirpuri, Aranyani

An alumnus of the Sri Sathya Sai Institute of Higher Learning, Haresh Mirpuri is a name to reckon with as he has created an Indian luxury handbag brand which embraces sustainability as a way of life. Handbags are known to be a woman’s best friend. Worldwide, fashion designers are playing with innovation to showcase their … Read more

Ayushman Bharat Digital Mission and the future of digitisation in the medical sciences – ET HealthWorld

Ayushman Bharat Digital Mission and the future of digitisation in the medical sciences – ET HealthWorld

by Dr. Jennifer Prabhu The current Ayushman Bharat Digital Mission by the PM to allow greater IT-penetration of healthcare is welcome news. What makes it doubly so, is the focus on digital health such as app-based solutions. This is because leveraging digital technology towards disease management and cure is very cost-effective. The Focus of this … Read more

Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Security firm – ET HealthWorld

Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Security firm – ET HealthWorld

NEW DELHI: A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country’s immunisation campaign, cyber intelligence firm Cyfirma told Reuters. Rivals China and India have both sold or gifted Covid-19 shots to many countries. India produces more than … Read more

Covaxin: Bharat Biotech granted permission to start Phase III trials for Covid-19 vaccine

Covaxin: Bharat Biotech granted permission to start Phase III trials for Covid-19 vaccine

Bharat Biotech has been granted permission to start the Phase III trials of Covaxin – India’s indigenous Covid-19 vaccine candidate. [REPRESENTATIVE IMAGE] File photo of Covaxin (Picture Courtesy: Twitter @airnewsalerts) The Drug Controller General of India (DGCI) on Thursday allowed Bharat Biotech International Limited to conduct the Phase III trials of its Covid-19 vaccine candidate … Read more